Mathew Lonberg, M.D.

A highly trained and committed hematologist and medical oncologist, Dr. Mathew Lonberg strives to provide his patients with excellent care in Rockland and surrounding areas. Board-certifications of his include a Diplomate in Hematology, Diplomate in Medical Oncology, and Diplomate in Internal Medicine. Dr. Lonberg is currently in private practice at Hematology Oncology Associates of Rockland, P.C. in Nyack, New York.

Dr. Lonberg graduated Magna Cum Laude from the University of Pennsylvania with honors in Biochemistry. Following his undergraduate education, he received his Doctor of Medicine at the University of Virginia School of Medicine where he was a member of the Alpha Omega Alpha Medical Honor Society. His post-graduate training began with an Internship in Medicine followed by a Residency in Medicine at New York University Hospital Medical Center at Bellevue Hospital in New York, NY. Dr. Lonberg continued his medical training at NYU Medical Center with a fellowship in Oncology Research. Afterwards, he joined a fellowship in Hematology and Oncology at Memorial Sloan-Kettering Cancer Center in New York, NY, where he achieved awards from the Charles H. Revson Foundation Fellowship in Biomedical Research and the American Cancer Society.

Dr. Lonberg is an attending physician at several hospitals in New York, including Nyack Hospital in Nyack, Good Samaritan Hospital in Suffern, and Columbia Presbyterian Medical Center in New York City. He is also Assistant Clinical Professor at Columbia University School of Medicine. Professional memberships of his include the American Society of Clinical Oncology, the American Society of Hematology, the New York State Society of Internal Medicine, and the American Medical Association. Dr. Lonberg is currently listed in Castle Connolly, Ltd – Americas Top Doctors, and has also published many scientific articles on various topics in oncology and hematology.

Publications:

• Muggia, F. and Lonberg, M. Kaposi's sarcoma and AIDS. Medical Clinics of North America 70:139­154, January 1984.
• Bystryn, J.C., Lonberg M. et ale Immunogenicity of the polyvalent melanoma antigen vaccine in patients with early melonoma. Proc AACR 26:1233, 1985 (abstr.)
• Lonberg, Odajnyk, C., Kriegel, R. et ale Sequential and simultaneous alpha-2 interferon (IFN) and VP16 in epidemic Kaposi's sarcoma. Proc Am Soc Clin Oncol 4:2, 1985 (abstr.)
• Krigel, R.L., Slywotzky, C.M., Lonberg, M. et ale Treatment of Epidemic Kaposi's Sarcoma with a combination of Interferon-Alpha 2b and Etoposide. Journal of Biological Response Modifiers 7:359 364, 1988.
• Lonberg, M., Bajorin, D., Cheung, N.K., Cordon, Cardo, C., Dantis, L., Templeton, M.A., Oettgen, H.F., Old, L., Houghton, A.N., et ale Phase I Trail of a combination of two mouse monoclonal antibodies (MABS) anti-GD3 (R24) and anti-GD2 (3FB) in patients (PTS) with melanoma and soft tissue sarcome (STS) (meeting abstract). Proc Am Soc Oncol 7:668, 1988.
• Chapman, P.B., Lonberg, M., Duteau, C., Houghton, A.N., et ale Analysis of variants of an anti-GD3 mouse monoclonal antibody: role of light chain in antigen binding, effector function, and tumor localization (meeting abstract). Proc AACR 29:1676, 1988.
• Houghton, A.N., Bajorin, D.F., Lonberg, M. et ale Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside Immunity to Cancer. II pp. 383-390; editor: M.S. Mitchell; Alan R. Liss, Inc., New York, 1989.
• Lonberg, M., Bains, M.S., McCormack, P.M. et ale The management of mediastinal germ cell tumors: the Memorial Sloan-Kettering experience. Thoracic Surgery: Frontiers and Uncommon Neoplasms Vol 5, pp. 233-236; editors: N. Martini and I. Vogt¬Moykopf; C.V. Mosby Co., st. Louis, MO., 1989.
• Chapman, P., Lonberg, M., Houghton, A.. Light chain variants of an IgG3 Anti-GD3 Monoclonal Antibody and the relationship among avidity, effector functions, tumor targeting and antitumor activity. Cancer Research 50:1503-1509, 1990.